Credit: Getty Images. The 2024 GOLD COPD Report includes updated research and recommendations that reflect shifts in thinking on COPD management. Vogelmeier, who heads the Department of Medicine, ...
The GOLD 2023 and 2024 reports recommend that health professionals consider triple therapy (TT) entailing combined use of a long-acting β 2 agonist (LABA), a long-acting muscarinic antagonist (LAMA), ...
AJMC®: What recent developments in the therapeutic landscape of chronic obstructive pulmonary disease (COPD) do you think have the greatest potential to shift how treatment is managed? Dr Martinez: ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果